TGFB1 and Hepatic fibrosis: We used two models to determine its effects: (1) an in vivo mouse model of liver fibrosis induced by the long-term injection of CCl4 and (2) an in vitro model based on LX-2 cells treated with or without TGF-β1 or LPS.